Delivery Order SPE2DB20D3303-SPE2DB25FA1TP
- Not listed
- The Defense Logistics Agency awarded a $18,644.24 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of July 28, 2025. This firm fixed price contract was competitively awarded without set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This...
- The Defense Logistics Agency awarded a $5,022.99 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count packages of Lidocaine 5% patches on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,399.62 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a performance period through March 14, 2024. This delivery order is issued under a larger, single-award indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency (DLA) awarded a $12,415.02 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of July 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems....
- The Defense Logistics Agency awarded a $2,438.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lidocaine 5% Patch 30s, with completion scheduled for July 22, 2025. This is a non-set-aside competitive award issued to the pharmaceutical distributor's Corporate Office in Conshohocken, Pennsylvania. The delivery order represents a routine medical procurement fulfilling the federal government's pharmaceutical supply needs for military and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $3,199.73 to Amerisourcebergen Drug Corp, a leading pharmaceutical sourcing and distribution company, for the supply of 4564119721 - Lidocaine 5% Patch 30s. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to provide a range of pharmaceutical products and medical supplies to DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Lidocaine 5% Patch 30s. The $1,130.91 contract has an ultimate completion date of April 8, 2024 and does not include any set-aside designation. This delivery order contract is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) that DLA previously awarded to AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $2,041.56 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units. Issued on July 21, 2025, with completion scheduled for July 22, 2025, this firm fixed-price contract represents a small-value pharmaceutical supply order to support federal medical procurement needs. The award utilizes no set-aside designation and reflects competitive procurement practices. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s valued at $7,743.88 with a firm fixed price structure. This non-set-aside award, issued on July 18, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $8,687.75. This competitively awarded, non-set-aside contract operates under firm fixed pricing with an ultimate completion date of July 21, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary distribution...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1TPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,770.55 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, executed through open competition. The contract is being performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office and primary pharmaceutical distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's contract portfolio demonstrates consistent capability in fulfilling federal medical procurement requirements through the DLA Medical Supply Chain, with deliveries spanning brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/25/25 |